ATAD1 and malaria: This simian vector has also been used in the development of other P. falciparum candidate malaria vaccines encoding the ME-TRAP [41] and MSP1 [32], [42] antigens, and was used in order to circumvent issues surrounding pre-existing anti-vector immunity to AdHu5 in humans.